2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




FDA Approves Vasorum’s Celt ACD Vascular Closure Device

July 21, 2016 -- Vasorum Ltd. announced US Food and Drug Administration approval of the Celt ACD vascular closure device, which is indicated for arterial puncture closure in b…

SNIS Prepares to Convene Annual Meeting in Boston

July 21, 2016 -- The Society of NeuroInterventional Surgery (SNIS) announced studies to be presented at the SNIS 13th Annual Meeting meeting, which will be held July…

Study Confirms Positive Effect of PAE for Patients With Benign Prostatic Hyperplasia

July 21, 2016 -- Findings from a study that sought to confirm whether prostatic artery embolization (PAE) has a positive medium- and long-term effect in patients with symptoma…

Essential Medical’s Manta Large-Bore Vascular Closure Device Approved in Europe

July 18, 2016 -- Essential Medical, Inc. announced that it has received European CE Mark approval for the company’s Manta large-bore vascular closure device. Manta …

European Postmarket Registry for Contego Medical’s Paladin Carotid System Completes Enrollment

July 20, 2016 -- Contego Medical, LLC announced it has completed enrollment in the Paladin carotid postdilation balloon system registry in Europe. The registry involved f…

Analysis Supports Abbott Vascular’s Supera Stent for Endovascular Treatment of Femoropopliteal Disease

July 20, 2016 -- A study of the initial United States experience in the endovascular management of lower extremity artery atherosclerotic disease with the Supera interwoven wi…

Click here for more News coverage

Current Supplements

Sponsored by GORE & ASSOCIATES

Value-Based Decisions for Dialysis Access

How practitioners of dialysis access creation and intervention are improving patient outcomes while reducing system costs.

Summer Supplement

Sponsored by Medtronic

Uncomplicating EVAR

Experts share how EndoAnchors are empowering physicians and aortic centers with unparalleled capabilities in the treatment of patients with aortic disease.

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

Featured Center






Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.